.RESEARCH STUDY HIGHLIGHT.06 August 2024.
A sizable randomized regulated test with cisgender women highlights the challenges of adherence to an everyday oral preexposure treatment routine and demonstrates that twice-yearly treatment of lenacapavir may preserve efficient HIV prevention amounts over 6 months.